Clinical Trial

Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 18, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on menstrual pain severity and premenstrual symptoms in women aged 18-30 years with primary dysmenorrhea. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be applied during the premenstrual and menstrual periods over approximately six months. The primary outcome is the change in menstrual pain severity, and secondary outcomes include changes in premenstrual symptom severity, analgesic use, and menstruation-related activity limitation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-08.
Status change: Not Yet Recruiting → Recruiting 2026-02-14
Trial Details
NCT Number NCT07409337
Lead Sponsor Nigde Omer Halisdemir University
Conditions Primary Dysmenorrhea, Premenstrual Syndrome, Menstrual Pain
Enrollment 120 participants
Start Date 2026-02-15
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-18